Suppr超能文献

姜黄素聚氰基丙烯酸正丁酯纳米粒的制备与表征

[Preparation and characterization of curcumin polybutylcyanoacrylate nanoparticles].

作者信息

Zhu Xiu-qing, Sun Min, Zhu Fan-ping, Ding Ting-ting, Zhai Ying-jie, Zhai Guang-xi

机构信息

College of Pharmacy, Shandong University, Jinan 250012, China.

出版信息

Zhong Yao Cai. 2010 May;33(5):797-801.

Abstract

OBJECTIVE

To prepare curcumin polybutylcyanoacrylate nanoparticles (Cur-PBCNs) and evaluate its characteristics.

METHODS

Cur-PBCNs were prepared by emulsion polymerization, and the formulation was optimized by L16 (4(3)) orthogonal design test with entrapment efficiency and drug loading as indices. In addition, its characteristics were investigated.

RESULTS

The nanoparticles were spherical in appearance under transmission electron microscope (TEM). The mean diameter of the nanoparticles was 93.8 nm, the mean entrapment efficiency was (50.4 +/- 2.2)%, the mean drug-loading was (33.5 +/- 0.9)% and the Zeta potential was -6.81 mV. The total drug release was 34.74% in 2 hours followed by a sustained release in vitro for Cur-PBCNs, and the in vitro release profile of the nanoparticles was fit for two phases kinetics equation: 100 - Q = 4.5235e(-0.1724t) + 4.1641e(-0.0114t).

CONCLUSION

The optimal Cur-PBCNs show good characteristics and sustained release character in vitro.

摘要

目的

制备姜黄素聚氰基丙烯酸正丁酯纳米粒(Cur-PBCNs)并评价其特性。

方法

采用乳液聚合法制备Cur-PBCNs,以包封率和载药量为指标,通过L16(4(3))正交设计试验优化处方。此外,对其特性进行了研究。

结果

透射电子显微镜(TEM)下纳米粒呈球形。纳米粒平均粒径为93.8nm,平均包封率为(50.4±2.2)%,平均载药量为(33.5±0.9)%,Zeta电位为-6.81mV。Cur-PBCNs在2小时内总药物释放率为34.74%,随后在体外呈缓释,纳米粒的体外释放曲线符合双相动力学方程:100 - Q = 4.5235e(-0.1724t) + 4.1641e(-0.0114t)。

结论

优化后的Cur-PBCNs具有良好的特性和体外缓释特性。

相似文献

5
Preparation and in vivo pharmacokinetics of curcumin-loaded PCL-PEG-PCL triblock copolymeric nanoparticles.
Int J Nanomedicine. 2012;7:4089-98. doi: 10.2147/IJN.S33607. Epub 2012 Jul 27.
6
7
Glutathione-responsive self-delivery nanoparticles assembled by curcumin dimer for enhanced intracellular drug delivery.
Int J Pharm. 2018 Oct 5;549(1-2):230-238. doi: 10.1016/j.ijpharm.2018.07.061. Epub 2018 Jul 31.
10
Reversion of multidrug resistance by co-encapsulation of doxorubicin and curcumin in chitosan/poly(butyl cyanoacrylate) nanoparticles.
Int J Pharm. 2012 Apr 15;426(1-2):193-201. doi: 10.1016/j.ijpharm.2012.01.020. Epub 2012 Jan 17.

引用本文的文献

1
Nanoformulations of curcumin: an emerging paradigm for improved remedial application.
Oncotarget. 2017 Jul 11;8(39):66680-66698. doi: 10.18632/oncotarget.19164. eCollection 2017 Sep 12.
2
Curcumin nanomedicine: a road to cancer therapeutics.
Curr Pharm Des. 2013;19(11):1994-2010. doi: 10.2174/138161213805289219.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验